Page last updated: 2024-10-21

hydroxyindoleacetic acid and Hypergonadotropic Hypogonadism

hydroxyindoleacetic acid has been researched along with Hypergonadotropic Hypogonadism in 2 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Research Excerpts

ExcerptRelevanceReference
"To characterize a disorder of episodes of flushing and increased levels of 5-hydroxyindoleacetic acid (5-HIAA) in men with secondary hypogonadism who respond to testosterone therapy."3.69Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy. ( Drake, AJ; Eisold, JF; Jasser, MZ; Shakir, KM; Yoshihashi, AK, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batt, RA1
Everard, DM1
Gillies, G1
Wilkinson, M1
Wilson, CA1
Yeo, TA1
Shakir, KM1
Jasser, MZ1
Yoshihashi, AK1
Drake, AJ1
Eisold, JF1

Other Studies

2 other studies available for hydroxyindoleacetic acid and Hypergonadotropic Hypogonadism

ArticleYear
Investigation into the hypogonadism of the obese mouse (genotype ob/ob).
    Journal of reproduction and fertility, 1982, Volume: 64, Issue:2

    Topics: Animals; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hydroxyindoleacetic A

1982
Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy.
    Mayo Clinic proceedings, 1996, Volume: 71, Issue:12

    Topics: Aged; Antineoplastic Agents, Hormonal; Flushing; Humans; Hydroxyindoleacetic Acid; Hypogonadism; Mal

1996